Main Library
CMMI releases three new models aimed at lower generic, novel drug costs

CMMI releases three new models aimed at lower generic, novel drug costs

February 14, 2023Robert KingFierce HealthcareMedicare ACOs/MSSP,Pharmacy Services

The Biden administration rolled out three new payment models intended to lower drug costs, including new Medicare coverage options for drugs cleared under accelerated approval.

The release of the three models on Tuesday is in response to an executive order President Biden delivered last year calling for the federal government to search for ways to lower prices.

“These selected models will test strategies to make it easier for Medicare patients to afford and access needed prescriptions at $2 or less, help expand access to cutting-edge cell and gene therapies for people with Medicaid, and help ensure drugs already on the market are safe and effective,” said Center for Medicare and Medicaid Innovation Director Liz Fowler in a statement.

Full Article

: ACO care teams, ACO participation, CMMI, CMMS, group practice, MSSP, SDOA, SDOH, SDOHY

Related Posts

How to Evaluate Physician Performance Using Appropriateness

March 30, 2022aco

ACO Execs Describe Painful Transition to eCQM Reporting

October 1, 2021Garrett Schmitt

Medicare, Medicaid innovation center lays out ambitious agenda for next decade

November 2, 2021Garrett Schmitt

Recent Posts

  • Alleviate end-of-year, value-based care gap closure anxiety
  • The SDOH Reality Check: Coding, Claims and Value-Based Care
  • RECORDED WEBINAR: HCC V28: Preparing for change: Actionable strategies from real world analysis
  • CMMI teases new behavioral, maternal health models launching this year
  • 5 challenges of chart chasing
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us